The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 55 | — | 20.1x | Near average | |
Growth | 56 | 20.6% | 5.6% | Near average | |
Quality | 25 | -191.4% | 7.6% | Below average | |
Safety | 27 | 0.9x | 0.4x | Below average | |
Capital Return | 27 | — | 2.19% | Below average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Exagen Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Exagen Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Exagen stock shows a state of complete stability in price targets over the past 30 days, as the average price target settled at 8.67 dollars, representing a significant price premium compared to the current price of 4.26 dollars. However, this stability reflects an absence of new catalysts or recent revisions by analysts, as current coverage is limited to only one analyst, which reduces the reliability of the statistical consensus and increases the ambiguity of the investment landscape.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.